<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Monitored anesthesia care in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Monitored anesthesia care in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Monitored anesthesia care in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric B Rosero, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Girish P Joshi, MB, BS, MD, FFARCSI</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marianna Crowley, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H653644357"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Monitored anesthesia care (MAC) is a type of anesthesia service in which an anesthesia clinician continually monitors and supports the patient's vital functions; diagnoses and treats clinical problems that occur; administers sedative, anxiolytic, or analgesic medications if needed; and converts to general anesthesia if required. Approximately one-third of ambulatory anesthesia services for diagnostic or therapeutic procedures in the United States are provided as MAC [<a href="#rid1">1</a>], often in out-of-operating-room locations.</p><p>This topic will discuss preoperative evaluation for patients who will receive MAC, monitoring during MAC, and the medications and sedation techniques commonly used during MAC. Procedural sedation by non-anesthesia clinicians and the drugs and techniques used for general anesthesia are discussed separately. (See  <a class="medical medical_review" href="/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications"</a> and  <a class="medical medical_review" href="/d/html/2567.html" rel="external">"Gastrointestinal endoscopy in adults: Procedural sedation administered by endoscopists"</a> and  <a class="medical medical_review" href="/d/html/94135.html" rel="external">"Induction of general anesthesia: Overview"</a> and  <a class="medical medical_review" href="/d/html/96308.html" rel="external">"Maintenance of general anesthesia: Overview"</a>.)</p><p>Sedation during procedures for which the primary anesthetic is a regional anesthesia technique, either neuraxial anesthesia or peripheral nerve block, is not considered MAC. However, the basic principles of sedation that are discussed here apply to those anesthetics as well.</p><p class="headingAnchor" id="H4134572060"><span class="h1">PREPROCEDURE EVALUATION</span><span class="headingEndMark"> — </span>A medical history and anesthesia-directed physical examination should be performed for all patients who undergo anesthesia, including those having MAC. Preoperative laboratory evaluation should be the same for MAC as it would be for general anesthesia (GA). (See  <a class="medical medical_review" href="/d/html/4816.html" rel="external">"Preoperative medical evaluation of the healthy adult patient", section on 'Laboratory evaluation'</a>.)</p><p class="headingAnchor" id="H1563215213"><span class="h2">Patient medical status</span><span class="headingEndMark"> — </span>The goals for preoperative evaluation are to identify underlying medical and physical conditions that may increase risk and to create an anesthetic plan that minimizes risk. In anticipation of MAC, the patient should be evaluated for conditions that increase sensitivity to sedative and analgesic medications (eg, older age; obstructive sleep apnea; advanced chronic lung disease; pulmonary hypertension; malnutrition [<a href="#rid2">2</a>]; coronary, liver, or renal disease; anxiety disorders; chronic pain; use of opioids, sedatives, or recreational drugs) to allow appropriate drug dosing and administration. According to the European Society of Anesthesiology guidelines for procedural sedation and analgesia, patients with the following comorbidities and conditions are at higher risk of complications: severe cardiovascular disease, documented or suspected risk of obstructive sleep apnea syndrome, morbid obesity, chronic renal failure, chronic hepatic disease (model for end-stage liver disease score &gt;10), age &gt;70 years, and American Society of Anesthesiologists' (ASA) physical status III to IV [<a href="#rid3">3</a>]. </p><p class="headingAnchor" id="H1343054924"><span class="h2">Airway evaluation</span><span class="headingEndMark"> — </span>Airway management may be necessary if sedation becomes deeper than intended or if GA is required during a planned MAC anesthetic. Therefore, the preoperative consultation should include an assessment of the airway  (<a class="graphic graphic_table graphicRef98505" href="/d/graphic/98505.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef108981" href="/d/graphic/108981.html" rel="external">table 2</a>) and risk factors for aspiration  (<a class="graphic graphic_table graphicRef98506" href="/d/graphic/98506.html" rel="external">table 3</a>) and education about routine preoperative fasting guidelines as for GA  (<a class="graphic graphic_table graphicRef94641" href="/d/graphic/94641.html" rel="external">table 4</a>). (See  <a class="medical medical_review" href="/d/html/91218.html" rel="external">"Airway management for induction of general anesthesia", section on 'Airway assessment'</a> and  <a class="medical medical_review" href="/d/html/91218.html" rel="external">"Airway management for induction of general anesthesia", section on 'Prediction of the difficult airway'</a> and  <a class="medical medical_review" href="/d/html/15698.html" rel="external">"Preoperative fasting in adults", section on 'Fasting guidelines'</a>.)</p><p class="headingAnchor" id="H3083243445"><span class="h2">Appropriateness of monitored anesthesia care</span><span class="headingEndMark"> — </span>The decision to use MAC must take into consideration the level of sedation required and whether the clinician will have easy access to the airway if immediate airway control is necessary. Procedures that limit access to the airway (eg, head and neck procedures, computed tomography [CT], or magnetic resonance imaging [MRI]) may be performed under light levels of sedation or under GA with airway control.</p><p>GA with endotracheal intubation may be a more appropriate choice than MAC for procedures that limit airway access and require deeper levels of sedation, especially in patients at high risk of aspiration if airway protective reflexes are diminished. Alternatively, for some procedures, regional anesthesia techniques (eg, peripheral nerve blocks, local anesthetic infiltration) or neuraxial anesthesia may be used to allow lighter levels of sedation that maintain airway reflexes.</p><p>When assessing the appropriateness of MAC, we also evaluate the following patient abilities:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lie motionless in the position required for the procedure </strong>–<strong> </strong>MAC may not be appropriate for procedures that require immobility in patients who may not be able to remain still in supine position without excessively deep sedation or general anesthesia (eg, essential tremor, persistent cough, orthopnea). Patients with arthritis or other joint problems may be unable to lie in the lateral position because of shoulder or hip pain, or prone because of neck pain, without excessively deep sedation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cooperate, if necessary </strong>–<strong> </strong>Patients with cognitive dysfunction, dementia, extreme anxiety, and barriers to communication may be unable to cooperate when necessary (eg, during awake craniotomy or thyroplasty).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Communicate with care providers </strong>–<strong> </strong>Verbal communication is required during MAC for assessment of the depth of sedation, explanation, and reassurance. Language barriers and hearing deficits may require a plan for communication aids during the procedure or may make general anesthesia a better choice than MAC.</p><p></p><p class="headingAnchor" id="H428702510"><span class="h2">Conversion from MAC to GA</span><span class="headingEndMark"> — </span>During the preoperative evaluation, the possibility of needing to convert to GA must always be considered. In a single institution retrospective study of over 200,000 MAC cases in adults, conversion to GA occurred in 0.5 percent of cases [<a href="#rid4">4</a>]. Frequent reasons for conversion included patient's inability to tolerate MAC, hypoxia or airway obstruction, failure of local/regional technique, aspiration, and unplanned extension of surgical area. Risk factors associated with conversion to GA included body mass index &gt;35 kg/m<sup>2</sup>; male sex; ASA physical status IV; anesthesia provider being a resident or nurse anesthetist rather than a solo attending; and procedures for oral and maxillofacial surgery, otorhinolaryngology, or orthopedic surgery [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H153026554"><span class="h2">Patient expectations</span><span class="headingEndMark"> — </span>Patients should realize that they may be aware and remember some or all of the procedure performed under sedation during MAC. Studies of patients who have reported awareness with recall have found that many patients expected to be unconscious during sedation or regional anesthesia [<a href="#rid5">5,6</a>]. Total lack of awareness and amnesia cannot be expected without general anesthesia. (See  <a class="medical medical_review" href="/d/html/400.html" rel="external">"Accidental awareness during general anesthesia", section on 'Management of patient expectations'</a>.) </p><p class="headingAnchor" id="H160831786"><span class="h1">MONITORING DURING MONITORED ANESTHESIA CARE</span></p><p class="headingAnchor" id="H1624107929"><span class="h2">Standard physiologic monitors</span><span class="headingEndMark"> — </span>In addition to clinical observation, standard American Society of Anesthesiologists (ASA) monitors should be employed during MAC (ie, electrocardiogram [ECG], noninvasive blood pressure [BP], oxygenation via pulse oximeter, temperature) [<a href="#rid7">7,8</a>] as they would be for general anesthesia. In addition, exhaled carbon dioxide (CO<sub>2</sub>) monitoring (capnography) is a standard monitor for patients who receive moderate or deep sedation or general anesthesia [<a href="#rid8">8,9</a>]. During sedation, capnography facilitates early detection of apnea and airway obstruction [<a href="#rid10">10</a>], predicts the development of hypoxemia [<a href="#rid11">11</a>], and may reduce patient injury related to respiratory depression [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/d/html/273.html" rel="external">"Carbon dioxide monitoring (capnography)", section on 'Procedural sedation'</a> and  <a class="medical medical_review" href="/d/html/100067.html" rel="external">"Basic patient monitoring during anesthesia", section on 'Capnography'</a>.)</p><p>More advanced cardiovascular monitoring (eg, intraarterial BP monitor) may be indicated based on patient factors and the planned procedure.</p><p class="headingAnchor" id="H1459608333"><span class="h2">Monitoring depth of sedation and analgesia</span><span class="headingEndMark"> — </span>Sedation is a continuum of drug-induced depression of consciousness that can range from wakefulness to general anesthesia [<a href="#rid13">13</a>]. If sedatives and/or analgesic medications are administered during MAC, the depth of sedation must be continually assessed to avoid oversedation or general anesthesia.</p><p class="headingAnchor" id="H2743659574"><span class="h3">Clinical assessment of sedation</span><span class="headingEndMark"> — </span>The ASA has created widely accepted definitions for minimal, moderate, and deep sedation based on responsiveness to verbal, tactile, and painful stimulation  (<a class="graphic graphic_table graphicRef109909" href="/d/graphic/109909.html" rel="external">table 5</a>). According to these definitions, patients who have received deep sedation respond only to either repeated or painful stimulation, may require airway intervention, and may have inadequate spontaneous ventilation. Importantly, any patient who is unarousable with a painful stimulus is, by definition, under general anesthesia.</p><p>In addition to the ASA definitions, other validated instruments for assessment of level of sedation that can be used during MAC include the Ramsay Sedation Scale  (<a class="graphic graphic_table graphicRef65842" href="/d/graphic/65842.html" rel="external">table 6</a>) [<a href="#rid14">14</a>] and the Modified Observer's Assessment of Alertness/Sedation Scale (MOASS)  (<a class="graphic graphic_table graphicRef110274" href="/d/graphic/110274.html" rel="external">table 7</a>) [<a href="#rid15">15</a>]. However, these scales are most commonly used in intensive care settings or for research purposes. In clinical practice, in the author's experience, depth of sedation is usually assessed by repeated evaluations of the patient's arousability.</p><p class="headingAnchor" id="H3996661609"><span class="h3">Processed electroencephalography</span><span class="headingEndMark"> — </span>Processed electroencephalography (EEG) monitors are often used during general anesthesia to provide information about the depth of anesthesia. The most commonly used device is the bispectral index (BIS) monitor, which provides a score from 0 to 100, with 100 representing the awake state; a score &lt;60 corresponds to general anesthesia [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/400.html" rel="external">"Accidental awareness during general anesthesia", section on 'Brain monitoring'</a>.)</p><p>The utility of processed EEG monitors for assessing the depth of sedation for MAC is unclear, and we do not routinely use BIS for these cases. The relationship between BIS values and the level of sedation varies among patients [<a href="#rid17">17</a>], and the literature on this correlation is conflicting. Several observational studies have reported good correlation between the BIS value and sedation scale scores [<a href="#rid18">18-22</a>], while others have reported poor correlation, especially during light to moderate sedation [<a href="#rid23">23-25</a>]. There is weak evidence to support the use of other processed EEG monitoring systems for MAC (eg, spectral entropy, Narcotrend, and SedLine) [<a href="#rid3">3</a>]. </p><p class="headingAnchor" id="H1181392080"><span class="h1">SUPPLEMENTAL OXYGEN</span><span class="headingEndMark"> — </span>Supplemental oxygen (O<sub>2</sub>) may not be necessary in patients with normal cardiopulmonary function having MAC with minimal sedation. In contrast, supplemental O<sub>2</sub> is usually required when MAC involves moderate or deep sedation/analgesia, as higher doses of intravenous (IV) analgesic and sedative medications can cause respiratory depression.</p><p>Open delivery of O<sub>2</sub> (eg, via nasal cannulae or a face mask) is a significant risk factor for operating room fire during procedures around the head and neck that require electrocautery. For such procedures, supplemental O<sub>2</sub> should be avoided, or limited to a concentration of &lt;30 percent. Risk of operating room fire and preventive strategies are discussed separately. (See  <a class="medical medical_review" href="/d/html/94592.html" rel="external">"Fire safety in the operating room", section on 'Management of open oxygen delivery systems'</a> and  <a class="medical medical_review" href="/d/html/94592.html" rel="external">"Fire safety in the operating room", section on 'Risk-based approach to fire prevention'</a>.) </p><p class="headingAnchor" id="H2720012704"><span class="h1">DRUGS USED FOR SEDATION AND ANALGESIA FOR MONITORED ANESTHESIA CARE</span><span class="headingEndMark"> — </span>In general, medications with rapid onset and short duration of action are preferred for sedation/analgesia during MAC to allow rapid titration of effects and quick recovery. Most of these medications have the potential to cause respiratory depression and hypotension  (<a class="graphic graphic_table graphicRef110394" href="/d/graphic/110394.html" rel="external">table 8</a>).</p><p>Doses should be modified based on patient factors (eg, doses reduced for older adults) and when combinations of drugs are administered.</p><p>We often use a balanced approach to the choice of sedative/analgesics, with a combination of sedatives and opioids or local anesthesia, to allow reduced doses of each class of drugs. Medications are often chosen based on clinician preference and familiarity, formulary issues, and cost.</p><p class="headingAnchor" id="H2121249337"><span class="h2">Benzodiazepines</span></p><p class="headingAnchor" id="H3023658334"><span class="h3">Midazolam</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">Midazolam</a> is a short-acting benzodiazepine with anxiolytic, amnesic, and sedative effects, without analgesic effects. Of the medications used for MAC, midazolam most reliably provides amnesia. Midazolam <strong>potentiates the effects of other sedatives and opioids</strong>, and can cause respiratory depression when given in high doses or with other sedatives or opioids. </p><p>The onset of action of an IV bolus of <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> occurs in approximately one to three minutes, with peak effect at approximately five minutes. The elimination half-life of midazolam is one to four hours [<a href="#rid26">26</a>].</p><p>A small dose of <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> (eg, 0.5 to 2 mg IV, doses adjusted in older adult patients) is commonly administered as premedication before entering the procedure room and is often administered before starting a <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> infusion. Midazolam premedication should be used cautiously in older adult patients, and is often avoided as part of enhanced recovery protocols. When used in small doses for premedication in low-risk patients, midazolam may have little effect on recovery. In a randomized trial of approximately 400 patients who underwent elective colonoscopy with propofol/opioid sedation with or without midazolam (0.04 mg/kg, maximum 5 mg) premedication, Postoperative Quality of Recovery Scores, including the cognitive domain scores, were similar at all time points in patients who received midazolam and those who did not [<a href="#rid27">27</a>]. Emergence and hospital discharge times were similar as well.</p><p>However, <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> is rarely used as the primary sedative for longer cases under MAC because repeated doses or infusions can result in sedation, confusion, and amnesia that lasts into the postoperative period. A number of studies comparing recovery after sedation during MAC have reported more rapid psychomotor recovery with <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> than with midazolam [<a href="#rid28">28-30</a>]. </p><p>The benzodiazepine antagonist <a class="drug drug_general" data-topicid="8456" href="/d/drug information/8456.html" rel="external">flumazenil</a> may be used to reverse the sedation induced by <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a>, but it has limited efficacy for reversal of respiratory depression caused by other types of drugs. Thus, patients with respiratory depression who have also received opioids should be treated with <a class="drug drug_general" data-topicid="9678" href="/d/drug information/9678.html" rel="external">naloxone</a>, an opioid antagonist, before or rather than flumazenil. The dose of flumazenil in adults is 0.2 mg IV given over 15 seconds, which may be repeated every minute to a maximum of 1 mg. The duration of action of flumazenil is approximately 20 to 40 minutes, which may be shorter than the residual effects of midazolam. Therefore, patients who have received flumazenil should be monitored for signs of resedation. In the event of resedation, flumazenil can be repeated at 20-minute intervals as needed, at 0.2 mg IV per minute, to a maximum dose of 1 mg, or 3 mg in an hour. When flumazenil is not available, some reports indicate that <a class="drug drug_general" data-topicid="8620" href="/d/drug information/8620.html" rel="external">aminophylline</a> (1 to 2 mg/kg IV over 5 minutes) can be at least partially effective in reversing sedation and respiratory depression caused by midazolam [<a href="#rid31">31-34</a>]. However, aminophylline should be used with caution in patients with seizures, cardiac or hepatic disease, and older adults.</p><p class="headingAnchor" id="H4090555477"><span class="h3">Remimazolam</span><span class="headingEndMark"> — </span>In 2020 the US Food and Drug Administration (FDA) approved <a class="drug drug_general" data-topicid="128915" href="/d/drug information/128915.html" rel="external">remimazolam</a>, a new short-acting benzodiazepine, for intravenous administration as a slow bolus. The drug uniquely exhibits the organ independent ester hydrolysis of <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a>, while retaining the gamma aminobutyric acid (GABA) agonist activities of <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a>. It can be safely used in patients with hepatic or renal impairment, without fear of prolonged duration of action, and can be reversed with <a class="drug drug_general" data-topicid="8456" href="/d/drug information/8456.html" rel="external">flumazenil</a>.</p><p>Because of its unique metabolism, <a class="drug drug_general" data-topicid="128915" href="/d/drug information/128915.html" rel="external">remimazolam</a> was expected to facilitate a faster recovery and earlier discharge from the postprocedure unit. Onset of clinical effect is similar to <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a>, whereas recovery is shorter [<a href="#rid35">35</a>]. However, the literature comparing remimazolam with other available agents is limited, and further study is required to determine its role in clinical care. </p><p>In our opinion, <a class="drug drug_general" data-topicid="128915" href="/d/drug information/128915.html" rel="external">remimazolam</a> does not provide significant advantages over <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> for most uses. The FDA labeling recommends 5 mg push injection over a one-minute time period followed by supplemental doses of 2.5 mg intravenously over a 15 second time period after at least two minutes. This regimen is impractical for very brief procedures (eg, upper GI endoscopy), and for longer procedures that would require repeated administration. Use of remimazolam for GI endoscopy is discussed separately. (See  <a class="medical medical_review" href="/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults", section on 'Remimazolam'</a>.) </p><p class="headingAnchor" id="H3175587877"><span class="h2">Propofol</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">Propofol</a> is a rapidly acting, short-acting sedative/hypnotic with modest amnestic and antiemetic properties at subhypnotic doses [<a href="#rid36">36,37</a>] without analgesic effects. Propofol is widely used for MAC because of its pharmacokinetic profile, including rapid effect site equilibration and short elimination half-time even after prolonged infusion. Thus, the depth of sedation can be adjusted rapidly, and patients recover quickly without residual psychomotor effects [<a href="#rid28">28-30</a>]. (See  <a class="medical medical_review" href="/d/html/139217.html" rel="external">"Procedural sedation in adults in the emergency department: Medication selection, dosing, and discharge criteria", section on 'Propofol'</a>.)</p><p><a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">Propofol</a> may be administered by intermittent boluses (eg, propofol ~20 mg IV). It is more commonly administered by titrated infusion (25 to 75 mcg/kg/minute), with or without an initial bolus.</p><p>Patients receiving <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> must be closely monitored for depth of sedation. Propofol has a narrow therapeutic index, meaning that patients may rapidly transition to deeper levels of sedation, including general anesthesia. There is no reversal agent for propofol, so oversedated patients must be managed with supportive measures, including proper airway management, until the drug wears off.</p><p><a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">Propofol</a> causes pain on injection in as many as 70 percent of patients [<a href="#rid38">38</a>]. A variety of methods for prevention and treatment of propofol pain have been used, including placement of intravenous (IV) catheters in antecubital veins rather than smaller veins, pretreatment with opioids, and injection of IV <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a>, with or without proximal vein occlusion [<a href="#rid39">39</a>]. In the author's experience, the most effective way to prevent pain due to propofol injection is to apply a tourniquet proximal to the IV site, inject 1% lidocaine 0.5 to 1 mg/kg IV, and wait 45 to 60 seconds before releasing the tourniquet and injecting propofol. Administration of lidocaine 20 to 30 mg IV just prior to a bolus of propofol may also be effective to minimize pain on injection. (See  <a class="medical medical_review" href="/d/html/139217.html" rel="external">"Procedural sedation in adults in the emergency department: Medication selection, dosing, and discharge criteria", section on 'Propofol'</a>.)</p><p class="headingAnchor" id="H2441489999"><span class="h2">Opioids</span><span class="headingEndMark"> — </span>Opioids are administered during MAC to provide analgesia for procedures in which local anesthesia may be ineffective or inappropriate, for local anesthetic infiltration or block placement, for uncomfortable positioning, or for <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> injection pain. Opioids with rapid onset and short duration of action are generally preferred. The most commonly used opioids for MAC are <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> and <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a>; the choice is often based on clinician preference, cost, duration of the procedure, and convenience. Remifentanil is more expensive than fentanyl and is only available as a powder that must be diluted for use.</p><p>Doses of opioids should be titrated to effect with both bolus and infusion techniques to minimize the risk of respiratory depression.</p><p>All opioids can cause intraoperative or postoperative nausea and vomiting (PONV), and prophylaxis for PONV during MAC should be considered as it would be for general anesthesia. We do not usually administer additional antiemetic medication during MAC that includes <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>, and we administer prophylaxis for other cases based on risk factors. (See  <a class="medical medical_review" href="/d/html/16849.html" rel="external">"Postoperative nausea and vomiting", section on 'Risk factors'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">Fentanyl</a><strong> </strong>–<strong> </strong>Fentanyl is typically used in small, intermittent IV boluses of 25 to 50 mcg IV, with reduced doses in older adults or when administered in combination with other sedatives/hypnotics. The onset of action is approximately one to three minutes, with peak effect in approximately six minutes. The duration of action of fentanyl is approximately 30 to 60 minutes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">Remifentanil</a><strong> </strong>–<strong> </strong>Remifentanil is an ultrashort-acting opioid with a very rapid onset of effect (60 to 90 seconds) and a context-sensitive half-time of elimination of approximately three minutes independent of the duration of infusion [<a href="#rid40">40</a>]. Remifentanil can be used to provide intense, titratable analgesia during stimulating portions of a procedure of any duration, without residual respiratory depression when stimulation is over.</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">Remifentanil</a> is usually administered as an infusion, with or without an initial or intermittent boluses. Commonly used doses, which should be adjusted for patient factors, are as follows. <strong>All doses should be reduced to half with concomitant </strong><a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a><strong> administration.</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Single dose 90 seconds prior to local anesthetic (LA) infiltration</strong> – <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">Remifentanil</a> 0.5 to 1 mcg/kg over 30 to 90 seconds.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Infusion</strong> – Beginning five minutes prior to LA infiltration, <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a> 0.1 mcg/kg/minute, wean to 0.05 mcg/kg/minute as tolerated (range 0.025 to 0.2 mcg/kg/minute) or target-controlled infusion at 1 to 3 ng/mL [<a href="#rid41">41</a>]. (See <a class="local">'Target-controlled infusion'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Intermittent boluses</strong> – <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">Remifentanil</a> 25 mcg IV over 15 to 30 seconds, or remifentanil 12.5 mcg IV over 15 to 30 seconds with background infusion [<a href="#rid42">42</a>].</p><p></p><p class="headingAnchor" id="H1728493177"><span class="h2">Dexmedetomidine</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">Dexmedetomidine</a> is a selective alpha<sub>2</sub>-adrenergic agonist with sedative, anxiolytic, and modest analgesic effects. In doses used for sedation, dexmedetomidine has been thought to have less respiratory depressant effects than other sedatives [<a href="#rid43">43,44</a>]. Clinical studies have reported a lower incidence of airway obstruction during sedation with dexmedetomidine compared with <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> [<a href="#rid45">45</a>]. However, some studies have reported upper respiratory obstruction and apneic episodes during sedation with dexmedetomidine, particularly during bolus administration [<a href="#rid46">46,47</a>]. In a small non-blinded randomized crossover volunteer study that compared the respiratory effects of dexmedetomidine or propofol at comparable degrees of sedation, the ventilatory response to hypoxia and hypercarbia were reduced to a similar degree with each drug [<a href="#rid48">48</a>]. In other randomized crossover volunteer studies, sedation with dexmedetomidine and propofol produced similar levels of upper airway collapse and reduced ventilatory drive [<a href="#rid49">49,50</a>]. Thus, dexmedetomidine should not be viewed as protective against respiratory depression or airway obstruction, particularly in high-risk patients. </p><p>The onset of action of <a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">dexmedetomidine</a> is relatively slow compared with other sedatives used for MAC. Clinical effects are often not seen until approximately 15 minutes after the start of a loading dose. In one study of sedation during regional anesthesia, targeted sedation was achieved within 10 minutes with a <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> infusion and took 25 minutes with dexmedetomidine [<a href="#rid51">51</a>]. Recovery from dexmedetomidine infusion is variable, with a context-sensitive half-time of elimination ranging from four minutes after a 10-minute infusion to 250 minutes after an eight-hour infusion [<a href="#rid52">52</a>].</p><p><a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">Dexmedetomidine</a> is usually administered with a loading dose of 0.5 to 1 mcg/kg IV over 10 minutes, followed by infusion at 0.2 to 1 mcg/kg/hour. Rapid administration and high doses may cause bradycardia and hypotension, or hypertension.</p><p><a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">Dexmedetomidine</a> has been used for sedation during MAC for a variety of procedures. The slow onset of action, hemodynamic effects, and prolonged sedation may make dexmedetomidine less suitable for some procedures (eg, cataract surgery [<a href="#rid53">53</a>], intra-arterial acute stroke therapy [<a href="#rid54">54</a>]) [<a href="#rid55">55,56</a>].</p><p class="headingAnchor" id="H2901777680"><span class="h2">Ketamine</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">Ketamine</a> produces a dissociative state accompanied by amnesia and intense analgesia with minimal respiratory depression at sedative doses (ketamine 0.25 to 0.5 mg/kg IV). We often administer small doses of ketamine during MAC to enhance analgesia and decrease the need for opioids.</p><p><a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">Ketamine</a> has a rapid onset of action (one minute) and a relatively short duration of action (10 to 20 minutes, with an elimination half-life of two to three hours) [<a href="#rid57">57,58</a>]. </p><p>During <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> sedation, the patient's eyes may remain open, and purposeful skeletal muscle movements are possible. Hemodynamic effects of ketamine include increases in heart rate (HR) and blood pressure (BP). However, ketamine can be cardio-depressant in patients with catecholamine depletion [<a href="#rid59">59</a>]. Adverse effects of ketamine include increased oral secretions that may lead to laryngospasm, and emergence reactions including vivid dreams and hallucinations. Concomitant use of benzodiazepines and other hypnotics and restriction of the dose to 0.25- to 0.5-mg/kg boluses with a maximum of 2 mg/kg over a 30-minute period may reduce the risk of such adverse effects [<a href="#rid60">60</a>].</p><p>The combination of <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> with <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> ("ketofol") has been administered for sedation, most commonly in the emergency department (ED) setting [<a href="#rid61">61</a>]. The benefits of this combination are unclear; the use of ketofol is discussed separately. (See  <a class="medical medical_review" href="/d/html/139217.html" rel="external">"Procedural sedation in adults in the emergency department: Medication selection, dosing, and discharge criteria", section on 'Premixed with propofol (ketofol)'</a>.)</p><p class="headingAnchor" id="H3297081394"><span class="h1">STRATEGY FOR MONITORED ANESTHESIA CARE</span><span class="headingEndMark"> — </span>Selection of medications and administration technique for MAC should be individualized to fit the needs of each particular patient (including medical issues that increase sensitivity to sedatives and opioids), the desired degree of sedation/analgesia, and the procedure to be performed. (See <a class="local">'Patient medical status'</a> above.)</p><p>There are many ways to provide safe and effective sedation/analgesia for MAC. Our usual approach to the choice of medications based on the degree and duration of expected painful stimulation is as follows.</p><p class="headingAnchor" id="H1188873391"><span class="h2">Procedures with minimal or no pain</span><span class="headingEndMark"> — </span>For short, painless diagnostic procedures (eg, magnetic resonance imaging [MRI], computed tomography [CT] scans), we often administer a bolus of <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> (1 to 2 mg IV) followed by small supplemental doses (eg, 0.5 to 1 mg IV) titrated to effect. Alternatively, for patients with morbid obesity, obstructive sleep apnea, acute or chronic pain, or severe anxiety, we administer <a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">dexmedetomidine</a> (0.1 to 0.7 mcg/kg/hour IV infusion) and may supplement with <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> (0.5 to 1 mg/kg IV).</p><p class="headingAnchor" id="H1262481989"><span class="h2">Procedures with brief, initial pain</span><span class="headingEndMark"> — </span>Procedures that involve only an initial, brief painful stimulus (eg, local anesthetic infiltration, peripheral nerve blocks, eye block, diagnostic puncture) usually require administration of larger doses of hypnotics or analgesics. A variety of drugs, alone or in combination, can be used. We usually administer <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> 1 to 2 mg IV with <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> 50 to 100 mcg IV, or <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> 0.5 to 1 mg/kg IV, or <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a> 0.5 to 1 mcg/kg IV over 60 to 90 seconds. For eye blocks for ophthalmologic surgery, we administer a bolus of propofol or remifentanil as described, and for local anesthesia or peripheral nerve blocks, we administer midazolam and fentanyl.</p><p class="headingAnchor" id="H397011628"><span class="h2">Procedures with variable pain throughout</span><span class="headingEndMark"> — </span>Infusions or repeated boluses of hypnotics and analgesics are usually used for procedures that cause variable degrees of pain throughout. Examples of such clinical scenarios are as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>For gastrointestinal endoscopy, we commonly administer <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> (initial bolus of 0.5 to 1 mg/kg followed by 25 to 75 mcg/kg/minute), supplemented as necessary with <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> 25 to 50 mcg or <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> 0.5 to 1 mg/kg IV.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For laryngeal framework procedures (eg, thyroplasty, arytenoid adduction), we usually administer <a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">dexmedetomidine</a> (0.3 to 0.7 mcg/kg/hour IV) with <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a> (0.03 to 0.04 mcg/kg/minute IV) [<a href="#rid62">62</a>]. This combination of medications has been described for MAC for electrophysiology procedures as well [<a href="#rid63">63</a>]. Alternatively, for patients who are at increased risk of airway obstruction or respiratory depression (eg, patients with obstructive sleep apnea or morbid obesity), we often administer dexmedetomidine (0.1 to 0.7 mcg/kg/hour IV infusion) and may supplement with <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> (0.5 to 1 mg/kg IV).</p><p></p><p class="headingAnchor" id="H3434306881"><span class="h1">DRUG ADMINISTRATION TECHNIQUES</span><span class="headingEndMark"> — </span>Anesthesia clinicians can administer sedative and analgesic medications for MAC by bolus administration, continuous infusion, or a combination of the two. Computer-controlled methods of administration (used primarily outside the United States) and patient-controlled methods of administration have also been used.</p><p class="headingAnchor" id="H525758841"><span class="h2">Bolus versus infusion</span><span class="headingEndMark"> — </span>The optimal method for drug delivery may depend on the duration and stimulation of the procedure and the drugs administered. In general, continuous infusion is often used for drugs with very short duration of action (eg, <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a>, <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a>) in an attempt to maintain stable blood levels of the drug. However, the benefits of continuous infusion versus intermittent bolus are not clear and may depend on the procedure and patients. Studies on the use of propofol for short gynecologic procedures, flexible bronchoscopy, and colonoscopy have reported that bolus techniques result in less total propofol administered, though with similar recovery times, compared with continuous infusion techniques [<a href="#rid64">64-66</a>].</p><p class="headingAnchor" id="H278617172"><span class="h2">Target-controlled infusion</span><span class="headingEndMark"> — </span>Target-controlled infusion (TCI) is a mode of drug administration with an infusion pump that uses pharmacokinetic models to calculate infusion rates necessary to achieve desired plasma or effect-site concentrations. The anesthesia clinician sets a desired effect-site target concentration (ie, mcg/mL or ng/mL) rather than the infusion rate that would be selected for a standard infusion pump (eg, mcg/kg/minute). The primary difference between TCI and manually adjusted infusion and/bolus administration is that the TCI system reduces infusion rates to account for drug distribution and elimination. Examples of plasma concentrations of <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> that correlate with different levels of sedation using TCI are shown in a table  (<a class="graphic graphic_table graphicRef110276" href="/d/graphic/110276.html" rel="external">table 9</a>).</p><p>The literature comparing the use of TCI systems with manual administration of sedatives is inconclusive. Some studies have reported faster recovery and a reduced incidence of respiratory depression with TCI for deep sedation [<a href="#rid67">67,68</a>]. However, there is no definitive evidence that, overall, TCI is clinically superior to manual methods of delivery of sedation.</p><p>TCI systems are not available in the United States.</p><p class="headingAnchor" id="H3577458696"><span class="h1">COMPLICATIONS DURING MONITORED ANESTHESIA CARE</span><span class="headingEndMark"> — </span>In contrast with popular belief, the overall rate of complications during and after MAC appears to be similar to that for general anesthesia [<a href="#rid69">69-73</a>]. The true incidence of anesthetic complications is notoriously difficult to ascertain, as many nonfatal complications are not reported. Nonetheless, data from the American Society of Anesthesiologists (ASA) Closed Claims Database suggest that, at least among cases that result in malpractice claims, the severity of injury for MAC cases is similar to claims after general anesthesia, with 40 percent of claims made for death or permanent brain damage [<a href="#rid12">12</a>]. The most common mechanism of injury in closed claims was respiratory depression resulting from oversedation, and nearly half of these were thought to have been preventable with better monitoring.</p><p>Patients who have MAC tend to be older and sicker and more commonly have anesthesia in offsite or out-of-operating-room locations, all of which increase the risk of complications [<a href="#rid74">74-76</a>]. (See  <a class="medical medical_review" href="/d/html/91909.html" rel="external">"Office-based anesthesia"</a> and  <a class="medical medical_review" href="/d/html/91608.html" rel="external">"Anesthesia for magnetic resonance imaging and computed tomography procedures"</a>.)</p><p>Potential complications include:</p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory complications, including airway obstruction, respiratory depression with hypoxemia and hypercarbia, and aspiration due to depression of airway reflexes. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular compromise, including hypotension, cardiac ischemia, cardiac arrest, and arrhythmias. (See  <a class="medical medical_review" href="/d/html/94357.html" rel="external">"Arrhythmias during anesthesia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complications related to patient movement (eg, protrusion of eye contents or eye injury during eye surgery).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Burn injuries, particularly involving the head and neck. (See  <a class="medical medical_review" href="/d/html/94592.html" rel="external">"Fire safety in the operating room"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Local anesthetic systemic toxicity (LAST). (See  <a class="medical medical_review" href="/d/html/397.html" rel="external">"Overview of peripheral nerve blocks", section on 'Local anesthetic systemic toxicity'</a>.)</p><p></p><p class="headingAnchor" id="H3353199884"><span class="h1">POST-ANESTHESIA CARE</span><span class="headingEndMark"> — </span>The pharmacologic effects of drugs used for sedation/analgesia usually extend beyond the duration of the therapeutic or diagnostic procedure. Monitoring and supplemental oxygen (O<sub>2</sub>) should be maintained while the patient recovers from the effects of the sedative medications. Patient care should be transferred to personnel in the phase I recovery area (post-anesthesia care unit [PACU]) capable of prompt detection of respiratory or cardiovascular compromise.</p><p>Patients who have completely recovered (ie, breathing spontaneously without need for any form of airway support, alert, speaking, responding appropriately to commands, and hemodynamically stable [<a href="#rid8">8</a>]) can be fast-tracked to the phase II recovery area (predischarge unit) for rapid discharge.</p><p class="headingAnchor" id="H2768412792"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/120318.html" rel="external">"Society guideline links: Procedural sedation in adults"</a>.)</p><p class="headingAnchor" id="H2467697470"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition of monitored anesthesia care (MAC) – </strong>During monitored anesthesia care (MAC), an anesthesia clinician continually monitors and supports the patient's vital functions; diagnoses and treats clinical problems that occur; administers sedative, anxiolytic, or analgesic medications if needed; and converts to general anesthesia if required.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preanesthesia evaluation – </strong>Preanesthesia evaluation and preparation for MAC should be the same as for those who will undergo general anesthesia (GA). The patient's ability to lie still, cooperate, and communicate, if necessary, should also be assessed. (See <a class="local">'Preprocedure evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring – </strong>Standard physiologic monitors should be employed during MAC, as they would be during general anesthesia. Capnography should be used for patients who receive moderate or deep sedation. (See <a class="local">'Standard physiologic monitors'</a> above.)</p><p></p><p class="bulletIndent1">In addition, the level of sedation should be assessed continually during MAC to avoid oversedation or general anesthesia. Any patient who is unarousable with a painful stimulus is, by definition, under general anesthesia. (See <a class="local">'Monitoring depth of sedation and analgesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Choice of medications</strong> – In general, we prefer medications with rapid onset and short duration of action to allow rapid titration of effects and quick recovery. (See <a class="local">'Drugs used for sedation and analgesia for monitored anesthesia care'</a> above.)</p><p></p><p class="bulletIndent1">Drugs commonly administered for MAC include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">Midazolam</a><strong> </strong>–<strong> </strong>Midazolam is a short-acting benzodiazepine with anxiolytic, amnesic, and sedative effects, without analgesic effects. Midazolam <strong>potentiates the effects of other sedatives and opioids</strong> and can cause respiratory depression when given in high doses or with other sedatives or opioids. (See <a class="local">'Midazolam'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">Propofol</a><strong> </strong>–<strong> </strong>Propofol is a rapidly acting, short-acting sedative/hypnotic with modest amnestic and antiemetic properties at subhypnotic doses, without analgesic effects. Propofol is commonly administered as an infusion. Patients may rapidly transition to deeper levels of sedation, including general anesthesia. (See <a class="local">'Propofol'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Opioids </strong>–<strong> </strong><a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">Fentanyl</a> and <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a> are the most commonly administered opioids during MAC. Fentanyl is a short-acting opioid that is usually administered by intermittent bolus. Remifentanil is an ultrashort-acting opioid that is often administered by infusion, with or without initial or supplemental bolus. Clinical recovery is very rapid after remifentanil, with an elimination half-life of approximately three minutes regardless of the duration of infusion. (See <a class="local">'Opioids'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">Dexmedetomidine</a> – Dexmedetomidine is a selective alpha<sub>2</sub>-adrenergic agonist with sedative, anxiolytic, and modest analgesic effects. In doses used for sedation, dexmedetomidine does not produce respiratory depression and maintains the normal ventilatory response to hypercarbia. With its slow onset of action, this drug is most useful for longer procedures and for patients who are at higher risk of respiratory depression or airway obstruction. (See <a class="local">'Dexmedetomidine'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">Ketamine</a><strong> </strong>–<strong> </strong>Ketamine produces a dissociative state accompanied by amnesia and intense analgesia with minimal respiratory depression at sedative doses. Ketamine can be administered as a supplement to other sedatives and analgesics to reduce the need for opioids. (See <a class="local">'Ketamine'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medication administration – </strong>Sedatives and analgesics may be administered by intravenous (IV) bolus, continuous infusion, or by a computer-assisted administration system. (See <a class="local">'Drug administration techniques'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Our approach – </strong>Our usual strategy for MAC, which is modified for patient factors that increase sensitivity to sedatives and opioids, is as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Procedures with minimal or no pain </strong>– For short, painless diagnostic procedures (eg, magnetic resonance imaging [MRI], computed tomography [CT] scans), we often administer a bolus of <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> (1 to 2 mg IV) followed by small, titrated supplemental doses (eg, 0.5 to 1 mg IV). For patients with morbid obesity, obstructive sleep apnea, acute or chronic pain, or severe anxiety, we administer <a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">dexmedetomidine</a> (0.1 to 0.7 mcg/kg/hour IV infusion) and may supplement with <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> (0.5 to 1 mg/kg IV).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Procedures with brief, initial pain </strong>–<strong> </strong>For procedures that involve only an initial, brief painful stimulus (eg, local anesthetic infiltration, peripheral nerve blocks, eye block, diagnostic puncture) we administer:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">Midazolam</a> 1 to 2 mg IV with <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> 50 to 100 mcg IV, </p><p class="bulletIndent3"><strong>or</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">Propofol</a> 0.5 to 1 mg/kg IV, </p><p class="bulletIndent3"><strong>or</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">Remifentanil</a> 0.5 to 1 mcg/kg IV</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Procedures with variable pain throughout </strong>– We use infusions or repeated boluses of hypnotics and analgesics for procedures that cause variable degrees of pain throughout. As examples:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For gastrointestinal endoscopy, we administer <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> (initial bolus of 0.5 to 1 mg/kg followed by 25 to 75 mcg/kg/minute), supplemented as necessary with <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> 25 to 50 mcg or <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> 0.5 to 1 mg/kg IV.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For laryngeal framework procedures (eg, thyroplasty, arytenoid adduction), we usually administer <a class="drug drug_general" data-topicid="8897" href="/d/drug information/8897.html" rel="external">dexmedetomidine</a> (0.3 to 0.7 mcg/kg/hour IV) with <a class="drug drug_general" data-topicid="9854" href="/d/drug information/9854.html" rel="external">remifentanil</a> (0.03 to 0.04 mcg/kg/minute IV). Alternatively, for patients who are at increased risk of airway obstruction or respiratory depression (eg, patients with obstructive sleep apnea or morbid obesity), we often administer dexmedetomidine (0.1 to 0.7 mcg/kg/hour IV infusion) and may supplement with <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> 0.5 to 1 mg/kg IV).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications – </strong>The rate of serious complications during and after MAC appears to be similar to that seen with general anesthesia. The most frequent mechanism for injury is respiratory depression due to oversedation, and in many cases, the injury may be preventable with appropriate monitoring. (See <a class="local">'Complications during monitored anesthesia care'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bayman EO, Dexter F, Laur JJ, Wachtel RE. National incidence of use of monitored anesthesia care. Anesth Analg 2011; 113:165.</a></li><li><a class="nounderline abstract_t">Tian X, Xiang Y, Fan Y, et al. Impact of malnutrition on propofol consumption and recovery time among patients undergoing laparoscopic gastrointestinal surgery. Acta Anaesthesiol Scand 2014; 58:942.</a></li><li><a class="nounderline abstract_t">Hinkelbein J, Lamperti M, Akeson J, et al. European Society of Anaesthesiology and European Board of Anaesthesiology guidelines for procedural sedation and analgesia in adults. Eur J Anaesthesiol 2018; 35:6.</a></li><li><a class="nounderline abstract_t">Kim S, Chang BA, Rahman A, et al. Analysis of urgent/emergent conversions from monitored anesthesia care to general anesthesia with airway instrumentation. BMC Anesthesiol 2021; 21:183.</a></li><li><a class="nounderline abstract_t">Bombardieri AM, Mathur S, Soares A, et al. Intraoperative Awareness With Recall: A Descriptive, Survey-Based, Cohort Study. Anesth Analg 2019; 129:1291.</a></li><li><a class="nounderline abstract_t">Pandit JJ, Andrade J, Bogod DG, et al. 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Br J Anaesth 2014; 113:549.</a></li><li class="breakAll">American Society of Anesthesiologists. Standards for Basic Anesthetic Monitoring (Approved by the ASA House of Delegates on October 21, 1986, last amended on October 20, 2010, and last affirmed on October 28, 2015). https://www.asahq.org/~/media/Sites/ASAHQ/Files/Public/Resources/standards-guidelines/standards-for-basic-anesthetic-monitoring.pdf (Accessed on April 06, 2016).</li><li><a class="nounderline abstract_t">Checketts MR, Alladi R, Ferguson K, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2016; 71:85.</a></li><li class="breakAll">http://www.asahq.org/quality-and-practice-management/standards-guidelines-and-related-resources/standards-for-basic-anesthetic-monitoring (Accessed on June 01, 2018).</li><li><a class="nounderline abstract_t">Soto RG, Fu ES, Vila H Jr, Miguel RV. Capnography accurately detects apnea during monitored anesthesia care. Anesth Analg 2004; 99:379.</a></li><li><a class="nounderline abstract_t">Srinivasa V, Kodali BS. Capnometry in the spontaneously breathing patient. Curr Opin Anaesthesiol 2004; 17:517.</a></li><li><a class="nounderline abstract_t">Bhananker SM, Posner KL, Cheney FW, et al. Injury and liability associated with monitored anesthesia care: a closed claims analysis. Anesthesiology 2006; 104:228.</a></li><li class="breakAll">American Society of Anesthesiologists. Position on Monitored Anesthesia Care (Approved by House of Delegates on October 25, 2005, and last amended on October 16, 2013). http://www.asahq.org/~/media/Sites/ASAHQ/Files/Public/Resources/standards-guidelines/position-on-monitored-anesthesia-care.pdf (Accessed on April 06, 2016).</li><li><a class="nounderline abstract_t">Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2:656.</a></li><li><a class="nounderline abstract_t">Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol 1990; 10:244.</a></li><li><a class="nounderline abstract_t">Liu J, Singh H, White PF. Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Anesth Analg 1997; 84:185.</a></li><li><a class="nounderline abstract_t">Ibrahim AE, Taraday JK, Kharasch ED. Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol. Anesthesiology 2001; 95:1151.</a></li><li><a class="nounderline abstract_t">Glass PS, Bloom M, Kearse L, et al. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997; 86:836.</a></li><li><a class="nounderline abstract_t">Sandler NA, Sparks BS. The use of bispectral analysis in patients undergoing intravenous sedation for third molar extractions. J Oral Maxillofac Surg 2000; 58:364.</a></li><li><a class="nounderline abstract_t">von Delius S, Thies P, Rieder T, et al. Auditory evoked potentials compared with bispectral index for monitoring of midazolam and propofol sedation during colonoscopy. Am J Gastroenterol 2009; 104:318.</a></li><li><a class="nounderline abstract_t">Kearse LA Jr, Rosow C, Zaslavsky A, et al. Bispectral analysis of the electroencephalogram predicts conscious processing of information during propofol sedation and hypnosis. Anesthesiology 1998; 88:25.</a></li><li><a class="nounderline abstract_t">Yu YH, Han DS, Kim HS, et al. Efficacy of bispectral index monitoring during balanced propofol sedation for colonoscopy: a prospective, randomized controlled trial. Dig Dis Sci 2013; 58:3576.</a></li><li><a class="nounderline abstract_t">Chisholm CJ, Zurica J, Mironov D, et al. Comparison of electrophysiologic monitors with clinical assessment of level of sedation. Mayo Clin Proc 2006; 81:46.</a></li><li><a class="nounderline abstract_t">Nishiyama T. Auditory evoked potentials index versus bispectral index during propofol sedation in spinal anesthesia. J Anesth 2009; 23:26.</a></li><li><a class="nounderline abstract_t">Weaver CS, Hauter WH, Duncan CE, et al. An assessment of the association of bispectral index with 2 clinical sedation scales for monitoring depth of procedural sedation. Am J Emerg Med 2007; 25:918.</a></li><li class="breakAll">https://dailymed.nlm.nih.gov (Accessed on September 20, 2016).</li><li><a class="nounderline abstract_t">Gurunathan U, Rahman T, Williams Z, et al. Effect of Midazolam in Addition to Propofol and Opiate Sedation on the Quality of Recovery After Colonoscopy: A Randomized Clinical Trial. Anesth Analg 2020; 131:741.</a></li><li><a class="nounderline abstract_t">Wilson E, David A, MacKenzie N, Grant IS. Sedation during spinal anaesthesia: comparison of propofol and midazolam. Br J Anaesth 1990; 64:48.</a></li><li><a class="nounderline abstract_t">White PF, Negus JB. Sedative infusions during local and regional anesthesia: a comparison of midazolam and propofol. J Clin Anesth 1991; 3:32.</a></li><li><a class="nounderline abstract_t">Wilson E, Mackenzie N, Grant IS. A comparison of propofol and midazolam by infusion to provide sedation in patients who receive spinal anaesthesia. Anaesthesia 1988; 43 Suppl:91.</a></li><li><a class="nounderline abstract_t">Aghabiklooei A, Sangsefidi J. The effects of intravenous aminophylline on level of consciousness in acute intentional benzodiazepines poisoning in comparison to flumazenil. Hum Exp Toxicol 2017; 36:311.</a></li><li><a class="nounderline abstract_t">Bonfiglio MF, Fisher-Katz LE, Saltis LM, et al. A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline. Pharmacotherapy 1996; 16:1166.</a></li><li><a class="nounderline abstract_t">Sibai AN, Sibai AM, Baraka A. Comparison of flumazenil with aminophylline to antagonize midazolam in elderly patients. Br J Anaesth 1991; 66:591.</a></li><li><a class="nounderline abstract_t">Gallen JS. Aminophylline reversal of midazolam sedation. Anesth Analg 1989; 69:268.</a></li><li><a class="nounderline abstract_t">Rogers WK, McDowell TS. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures. IDrugs 2010; 13:929.</a></li><li><a class="nounderline abstract_t">Veselis RA, Reinsel RA, Feshchenko VA, Johnson R Jr. Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine. Anesthesiology 2004; 101:831.</a></li><li><a class="nounderline abstract_t">Veselis RA, Reinsel RA, Feshchenko VA, Wroński M. The comparative amnestic effects of midazolam, propofol, thiopental, and fentanyl at equisedative concentrations. Anesthesiology 1997; 87:749.</a></li><li><a class="nounderline abstract_t">Picard P, Tramèr MR. Prevention of pain on injection with propofol: a quantitative systematic review. Anesth Analg 2000; 90:963.</a></li><li><a class="nounderline abstract_t">Jalota L, Kalira V, George E, et al. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ 2011; 342:d1110.</a></li><li><a class="nounderline abstract_t">Egan TD. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal. Clin Pharmacokinet 1995; 29:80.</a></li><li><a class="nounderline abstract_t">Byun SH, Hwang DY, Hong SW, Kim SO. Target-controlled infusion of remifentanil for conscious sedation during spinal anesthesia. Korean J Anesthesiol 2011; 61:195.</a></li><li><a class="nounderline abstract_t">Sá Rêgo MM, Inagaki Y, White PF. Remifentanil administration during monitored anesthesia care: are intermittent boluses an effective alternative to a continuous infusion? Anesth Analg 1999; 88:518.</a></li><li><a class="nounderline abstract_t">Hsu YW, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004; 101:1066.</a></li><li><a class="nounderline abstract_t">Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93:382.</a></li><li><a class="nounderline abstract_t">Chang ET, Certal V, Song SA, et al. Dexmedetomidine versus propofol during drug-induced sleep endoscopy and sedation: a systematic review. Sleep Breath 2017; 21:727.</a></li><li><a class="nounderline abstract_t">Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77:1125.</a></li><li><a class="nounderline abstract_t">Mahmoud M, Radhakrishman R, Gunter J, et al. Effect of increasing depth of dexmedetomidine anesthesia on upper airway morphology in children. Paediatr Anaesth 2010; 20:506.</a></li><li><a class="nounderline abstract_t">Lodenius Å, Ebberyd A, Hårdemark Cedborg A, et al. Sedation with Dexmedetomidine or Propofol Impairs Hypoxic Control of Breathing in Healthy Male Volunteers: A Nonblinded, Randomized Crossover Study. Anesthesiology 2016; 125:700.</a></li><li><a class="nounderline abstract_t">Lodenius Å, Maddison KJ, Lawther BK, et al. Upper Airway Collapsibility during Dexmedetomidine and Propofol Sedation in Healthy Volunteers: A Nonblinded Randomized Crossover Study. Anesthesiology 2019; 131:962.</a></li><li><a class="nounderline abstract_t">Mishima G, Sanuki T, Sato S, et al. Upper-airway collapsibility and compensatory responses under moderate sedation with ketamine, dexmedetomidine, and propofol in healthy volunteers. Physiol Rep 2020; 8:e14439.</a></li><li><a class="nounderline abstract_t">Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg 2002; 95:461.</a></li><li><a class="nounderline abstract_t">Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret. Br J Anaesth 2002; 88:669.</a></li><li><a class="nounderline abstract_t">Alhashemi JA. Dexmedetomidine vs midazolam for monitored anaesthesia care during cataract surgery. Br J Anaesth 2006; 96:722.</a></li><li><a class="nounderline abstract_t">John S, Somal J, Thebo U, et al. Safety and Hemodynamic Profile of Propofol and Dexmedetomidine Anesthesia during Intra-arterial Acute Stroke Therapy. J Stroke Cerebrovasc Dis 2015; 24:2397.</a></li><li><a class="nounderline abstract_t">Jalowiecki P, Rudner R, Gonciarz M, et al. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology 2005; 103:269.</a></li><li><a class="nounderline abstract_t">Zeyneloglu P, Pirat A, Candan S, et al. Dexmedetomidine causes prolonged recovery when compared with midazolam/fentanyl combination in outpatient shock wave lithotripsy. Eur J Anaesthesiol 2008; 25:961.</a></li><li><a class="nounderline abstract_t">Darnobid JA. The pharmacology of total intravenous anesthesia. Int Anesthesiol Clin 2015; 53:13.</a></li><li><a class="nounderline abstract_t">Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg 1998; 87:1186.</a></li><li><a class="nounderline abstract_t">Loh G, Dalen D. Low-dose ketamine in addition to propofol for procedural sedation and analgesia in the emergency department. Ann Pharmacother 2007; 41:485.</a></li><li><a class="nounderline abstract_t">Hession PM, Joshi GP. Sedation: not quite that simple. Anesthesiol Clin 2010; 28:281.</a></li><li><a class="nounderline abstract_t">Badrinath S, Avramov MN, Shadrick M, et al. The use of a ketamine-propofol combination during monitored anesthesia care. Anesth Analg 2000; 90:858.</a></li><li><a class="nounderline abstract_t">Rosero EB, Ozayar E, Mau T, Joshi GP. A sequential anesthesia technique for surgical repair of unilateral vocal fold paralysis. J Anesth 2016; 30:1078.</a></li><li><a class="nounderline abstract_t">Cho JS, Shim JK, Na S, et al. Improved sedation with dexmedetomidine-remifentanil compared with midazolam-remifentanil during catheter ablation of atrial fibrillation: a randomized, controlled trial. Europace 2014; 16:1000.</a></li><li><a class="nounderline abstract_t">Brownlie GS, Baker JA, Ogg TW. Propofol: bolus or continuous infusion. A day case technique for the vaginal termination of pregnancy. Anaesthesia 1991; 46:775.</a></li><li><a class="nounderline abstract_t">González-Santiago JM, Martín-Noguerol E, Vinagre-Rodríguez G, et al. Intermittent boluses versus pump continuous infusion for endoscopist-directed propofol administration in colonoscopy. Rev Esp Enferm Dig 2013; 105:378.</a></li><li><a class="nounderline abstract_t">Grendelmeier P, Tamm M, Pflimlin E, Stolz D. Propofol sedation for flexible bronchoscopy: a randomised, noninferiority trial. Eur Respir J 2014; 43:591.</a></li><li><a class="nounderline abstract_t">Chiang MH, Wu SC, You CH, et al. Target-controlled infusion vs. manually controlled infusion of propofol with alfentanil for bidirectional endoscopy: a randomized controlled trial. Endoscopy 2013; 45:907.</a></li><li><a class="nounderline abstract_t">Moerman AT, Herregods LL, De Vos MM, et al. Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients. Anesth Analg 2009; 108:828.</a></li><li><a class="nounderline abstract_t">Domino KB. Trends in anesthesia litigation in the 1990's: Monitored anesthesia care claims. ASA Newsl 1997; 61:15.</a></li><li><a class="nounderline abstract_t">Franz R, Hartman J, Wright M. Comparison of anesthesia technique on outcomes of endovascular repair of abdominal aortic aneurysms: a five-year review of monitored anesthesia care with local anesthesia vs. general or regional anesthesia. J Cardiovasc Surg (Torino) 2011; 52:567.</a></li><li><a class="nounderline abstract_t">Liu J, Martinez-Wilson H, Neuman MD, et al. Outcome of Carotid Endarterectomy after Regional Anesthesia versus General Anesthesia - A Retrospective Study Using Two Independent Databases. Transl Perioper Pain Med 2014; 1:14.</a></li><li><a class="nounderline abstract_t">Snyder SK, Roberson CR, Cummings CC, Rajab MH. Local Anesthesia With Monitored Anesthesia Care vs General Anesthesia in Thyroidectomy: A Randomized Study. Arch Surg 2006; 141:167.</a></li><li><a class="nounderline abstract_t">Vu MM, Galiano RD, Souza JM, et al. A multi-institutional, propensity-score-matched comparison of post-operative outcomes between general anesthesia and monitored anesthesia care with intravenous sedation in umbilical hernia repair. Hernia 2016; 20:517.</a></li><li><a class="nounderline abstract_t">Metzner J, Posner KL, Domino KB. The risk and safety of anesthesia at remote locations: the US closed claims analysis. Curr Opin Anaesthesiol 2009; 22:502.</a></li><li><a class="nounderline abstract_t">Woodward ZG, Urman RD, Domino KB. Safety of Non-Operating Room Anesthesia: A Closed Claims Update. Anesthesiol Clin 2017; 35:569.</a></li><li><a class="nounderline abstract_t">Chang B, Kaye AD, Diaz JH, et al. Interventional Procedures Outside of the Operating Room: Results From the National Anesthesia Clinical Outcomes Registry. J Patient Saf 2018; 14:9.</a></li></ol></div><div id="topicVersionRevision">Topic 94529 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21596866" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : National incidence of use of monitored anesthesia care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25060045" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Impact of malnutrition on propofol consumption and recovery time among patients undergoing laparoscopic gastrointestinal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28877145" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : European Society of Anaesthesiology and European Board of Anaesthesiology guidelines for procedural sedation and analgesia in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34187367" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Analysis of urgent/emergent conversions from monitored anesthesia care to general anesthesia with airway instrumentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31453869" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Intraoperative Awareness With Recall: A Descriptive, Survey-Based, Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25204697" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25204697" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26582586" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26582586" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15271710" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Capnography accurately detects apnea during monitored anesthesia care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17031088" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Capnometry in the spontaneously breathing patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16436839" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Injury and liability associated with monitored anesthesia care: a closed claims analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16436839" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Injury and liability associated with monitored anesthesia care: a closed claims analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4835444" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Controlled sedation with alphaxalone-alphadolone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2286697" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8989022" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11684984" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9105228" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10759114" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The use of bispectral analysis in patients undergoing intravenous sedation for third molar extractions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19190608" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Auditory evoked potentials compared with bispectral index for monitoring of midazolam and propofol sedation during colonoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9447852" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Bispectral analysis of the electroencephalogram predicts conscious processing of information during propofol sedation and hypnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23982208" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Efficacy of bispectral index monitoring during balanced propofol sedation for colonoscopy: a prospective, randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16438478" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Comparison of electrophysiologic monitors with clinical assessment of level of sedation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19234818" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Auditory evoked potentials index versus bispectral index during propofol sedation in spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17920977" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : An assessment of the association of bispectral index with 2 clinical sedation scales for monitoring depth of procedural sedation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17920977" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : An assessment of the association of bispectral index with 2 clinical sedation scales for monitoring depth of procedural sedation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31922999" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effect of Midazolam in Addition to Propofol and Opiate Sedation on the Quality of Recovery After Colonoscopy: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2302376" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Sedation during spinal anaesthesia: comparison of propofol and midazolam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2007040" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sedative infusions during local and regional anesthesia: a comparison of midazolam and propofol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3259111" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A comparison of propofol and midazolam by infusion to provide sedation in patients who receive spinal anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27142356" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The effects of intravenous aminophylline on level of consciousness in acute intentional benzodiazepines poisoning in comparison to flumazenil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8947991" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2031820" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Comparison of flumazenil with aminophylline to antagonize midazolam in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2764304" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Aminophylline reversal of midazolam sedation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21154153" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15448514" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9357875" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The comparative amnestic effects of midazolam, propofol, thiopental, and fentanyl at equisedative concentrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10735808" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Prevention of pain on injection with propofol: a quantitative systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21406529" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Prevention of pain on injection of propofol: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7586903" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22025939" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Target-controlled infusion of remifentanil for conscious sedation during spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10071997" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Remifentanil administration during monitored anesthesia care: are intermittent boluses an effective alternative to a continuous infusion?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15505441" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10910487" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The effects of increasing plasma concentrations of dexmedetomidine in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28130737" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Dexmedetomidine versus propofol during drug-induced sleep endoscopy and sedation: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1361310" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20412456" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Effect of increasing depth of dexmedetomidine anesthesia on upper airway morphology in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27483127" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Sedation with Dexmedetomidine or Propofol Impairs Hypoxic Control of Breathing in Healthy Male Volunteers: A Nonblinded, Randomized Crossover Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31403974" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Upper Airway Collapsibility during Dexmedetomidine and Propofol Sedation in Healthy Volunteers: A Nonblinded Randomized Crossover Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32441458" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Upper-airway collapsibility and compensatory responses under moderate sedation with ketamine, dexmedetomidine, and propofol in healthy volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12145072" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12067004" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16595611" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Dexmedetomidine vs midazolam for monitored anaesthesia care during cataract surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26231475" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Safety and Hemodynamic Profile of Propofol and Dexmedetomidine Anesthesia during Intra-arterial Acute Stroke Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16052108" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18538051" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Dexmedetomidine causes prolonged recovery when compared with midazolam/fentanyl combination in outpatient shock wave lithotripsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25807015" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The pharmacology of total intravenous anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9806706" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Ketamine: teaching an old drug new tricks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17341533" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Low-dose ketamine in addition to propofol for procedural sedation and analgesia in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20488395" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Sedation: not quite that simple.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10735789" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The use of a ketamine-propofol combination during monitored anesthesia care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27522215" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A sequential anesthesia technique for surgical repair of unilateral vocal fold paralysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24381332" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Improved sedation with dexmedetomidine-remifentanil compared with midazolam-remifentanil during catheter ablation of atrial fibrillation: a randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1928683" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Propofol: bolus or continuous infusion. A day case technique for the vaginal termination of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24206547" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Intermittent boluses versus pump continuous infusion for endoscopist-directed propofol administration in colonoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23900984" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Propofol sedation for flexible bronchoscopy: a randomised, noninferiority trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24165817" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Target-controlled infusion vs. manually controlled infusion of propofol with alfentanil for bidirectional endoscopy: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19224790" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Trends in anesthesia litigation in the 1990's: Monitored anesthesia care claims</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22034673" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Comparison of anesthesia technique on outcomes of endovascular repair of abdominal aortic aneurysms: a five-year review of monitored anesthesia care with local anesthesia vs. general or regional anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26023678" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Outcome of Carotid Endarterectomy after Regional Anesthesia versus General Anesthesia - A Retrospective Study Using Two Independent Databases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16490894" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Local Anesthesia With Monitored Anesthesia Care vs General Anesthesia in Thyroidectomy: A Randomized Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26860730" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : A multi-institutional, propensity-score-matched comparison of post-operative outcomes between general anesthesia and monitored anesthesia care with intravenous sedation in umbilical hernia repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19506473" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The risk and safety of anesthesia at remote locations: the US closed claims analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29101947" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Safety of Non-Operating Room Anesthesia: A Closed Claims Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29461406" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Interventional Procedures Outside of the Operating Room: Results From the National Anesthesia Clinical Outcomes Registry.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
